Genna Alessandro, Duran Camille L, Entenberg David, Condeelis John S, Cox Dianne
Department of Developmental and Molecular Biology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY 10461, USA.
Department of Cell Biology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY 10461, USA.
Cancers (Basel). 2023 Mar 31;15(7):2092. doi: 10.3390/cancers15072092.
Macrophages are important players involved in the progression of breast cancer, including in seeding the metastatic niche. However, the mechanism by which macrophages in the lung parenchyma interact with tumor cells in the vasculature to promote tumor cell extravasation at metastatic sites is not clear. To mimic macrophage-driven tumor cell extravasation, we used an in vitro assay (eTEM) in which an endothelial monolayer and a matrigel-coated filter separated tumor cells and macrophages from each other. The presence of macrophages promoted tumor cell extravasation, while macrophage conditioned media was insufficient to stimulate tumor cell extravasation in vitro. This finding is consistent with a requirement for direct contact between macrophages and tumor cells. We observed the presence of Thin Membranous Connections (TMCs) resembling similar structures formed between macrophages and tumor cells called tunneling nanotubes, which we previously demonstrated to be important in tumor cell invasion in vitro and in vivo. To determine if TMCs are important for tumor cell extravasation, we used macrophages with reduced levels of endogenous M-Sec (TNFAIP2), which causes a defect in tunneling nanotube formation. As predicted, these macrophages showed reduced macrophage-tumor cell TMCs. In both, human and murine breast cancer cell lines, there was also a concomitant reduction in tumor cell extravasation in vitro when co-cultured with M-Sec deficient macrophages compared to control macrophages. We also detected TMCs formed between macrophages and tumor cells through the endothelial layer in the eTEM assay. Furthermore, tumor cells were more frequently found in pores under the endothelium that contain macrophage protrusions. To determine the role of macrophage-tumor cell TMCs in vivo, we generated an M-Sec deficient mouse. Using an in vivo model of experimental metastasis, we detected a significant reduction in the number of metastatic lesions in M-Sec deficient mice compared to wild type mice. There was no difference in the size of the metastases, consistent with a defect specific to tumor cell extravasation and not metastatic outgrowth. Additionally, with an examination of time-lapse intravital-imaging (IVI) data sets of breast cancer cell extravasation in the lungs, we could detect the presence of TMCs between extravascular macrophages and vascular tumor cells. Overall, our data indicate that macrophage TMCs play an important role in promoting the extravasation of circulating tumor cells in the lungs.
巨噬细胞是参与乳腺癌进展的重要因素,包括在构建转移微环境方面。然而,肺实质中的巨噬细胞与脉管系统中的肿瘤细胞相互作用以促进转移部位肿瘤细胞外渗的机制尚不清楚。为了模拟巨噬细胞驱动的肿瘤细胞外渗,我们使用了一种体外实验(eTEM),其中内皮细胞单层和基质胶包被的滤膜将肿瘤细胞和巨噬细胞彼此分开。巨噬细胞的存在促进了肿瘤细胞外渗,而巨噬细胞条件培养基在体外不足以刺激肿瘤细胞外渗。这一发现与巨噬细胞和肿瘤细胞之间需要直接接触一致。我们观察到存在类似于巨噬细胞与肿瘤细胞之间形成的称为隧道纳米管的类似结构的薄膜连接(TMC),我们之前证明其在体外和体内的肿瘤细胞侵袭中很重要。为了确定TMC对肿瘤细胞外渗是否重要,我们使用了内源性M-Sec(TNFAIP2)水平降低的巨噬细胞,这会导致隧道纳米管形成缺陷。正如所预测的,这些巨噬细胞显示出巨噬细胞 - 肿瘤细胞TMC减少。在人源和鼠源乳腺癌细胞系中,与对照巨噬细胞共培养时,体外肿瘤细胞外渗也随之减少。我们还在eTEM实验中检测到通过内皮细胞层在巨噬细胞和肿瘤细胞之间形成的TMC。此外,在内皮细胞下方含有巨噬细胞突起的孔隙中更频繁地发现肿瘤细胞。为了确定巨噬细胞 - 肿瘤细胞TMC在体内的作用,我们构建了一只M-Sec缺陷小鼠。使用实验性转移的体内模型,我们检测到与野生型小鼠相比,M-Sec缺陷小鼠的转移灶数量显著减少。转移灶的大小没有差异,这与肿瘤细胞外渗而非转移灶生长的特异性缺陷一致。此外,通过检查乳腺癌细胞在肺中渗出的延时活体成像(IVI)数据集,我们可以检测到血管外巨噬细胞和血管内肿瘤细胞之间存在TMC。总体而言,我们的数据表明巨噬细胞TMC在促进循环肿瘤细胞在肺中的外渗中起重要作用。